Du traitement du diabète à la perte de poids et la prévention du risque cardiovasculaire, les agonistes du GLP-1 ont élargi au fil des années leurs bénéfices et leurs indications. C’est un nouveau bil ...
“Partnering with GreenBe Pharma propels our mission to increase global accessibility to premium cannabis genetics,” said Jamie Blundell, CEO of Segra International. “This alliance underscores our ...
Since initiation of the program, the following transactions have been made: The details for each transaction made under the share repurchase program are published on bavarian-nordic.com.
Mont-Saint-Guibert (Belgique), le 20 janvier 2025, 22:30h CET / 16:30h ET – Conformément à l'article 14 de la loi du 2 mai 2007 relative à la publicité des participations importantes, Nyxoah SA ...
The Company also announced today that the TSXV has granted an extension to the deadline for the completion of the Offering to February 17, 2025. The Company anticipates having an additional closing of ...
“We’re pleased to complete the acquisition and add two new territories in Nova Scotia,” said Dana Hatfield, Chair of the Board of Nova Leap. “We are looking forward to working with the existing ...
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported further positive Phase 3 data in adolescents for its single-shot chikungunya virus (CHIKV) vaccine, IXCHIQ ® ...
Toripalimab, independently developed by Junshi Biosciences, is a monoclonal antibody targeting PD-1 for the treatment of multiple malignant tumors. To date, toripalimab has been approved for marketing ...
Accèdez sans limite aux 15 000 actualités du site et recevez gratuitement chaque semaine, la Newsletter Santé log avec les actus Santé à ne pas manquer !